Berylson Capital Partners’s CM Life Sciences II Inc. Unit CMIIU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-384,164
Closed -$5.17M 68
2021
Q2
$5.17M Hold
384,164
1.15% 35
2021
Q1
$4.92M Buy
+384,164
New +$4.82M 1.2% 29

Berylson Capital Partners's CMIIU Position: Q3 2021 in Review

Berylson Capital Partners sold out of CM Life Sciences II Inc. Unit (CMIIU) in Q3 2021, closing a stake of 384,164 shares — an estimated $5.17M sold.

Berylson Capital Partners first reported a position in CMIIU in Q1 2021 and held it in 2 quarters. The position peaked at $5.17M in Q2 2021. 0 funds tracked by Wall St. Rank hold CMIIU as of Q3 2021.

  • Berylson Capital Partners reported no remaining CM Life Sciences II Inc. Unit position as of Q3 2021 after selling out during the quarter.
  • Berylson Capital Partners sold 384,164 CM Life Sciences II Inc. Unit shares in Q3 2021, an estimated $5.17M.
  • Berylson Capital Partners first reported a position in CM Life Sciences II Inc. Unit in Q1 2021 and held it in 2 quarters.
  • Berylson Capital Partners's CM Life Sciences II Inc. Unit position peaked at $5.17M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held CM Life Sciences II Inc. Unit as of Q3 2021.

Based on Berylson Capital Partners's 13F filing for Q3 2021, filed 15 Nov 2021.